Codexis, Inc. CDXS Cash Flow

Codexis, inc. (CDXS)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09
Operating activities:
Net loss
-11,935	-10,878	-22,996	-8,558	-7,581	-19,071	-41,303	-30,857	-16,550	-8,541	-20,289
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of intangible assets
-	-	-	2,812	3,374	3,374	3,374	3,509	3,716	1,063	957
Depreciation
1,570	1,147	1,042	1,734	2,035	3,311	6,944	8,908	7,755	7,246	5,172
Amortization expense - right-of-use assets - operating and finance leases
2,987	0	0	-	-	-	-	-	-	-	-
Amortization of debt discount
-	-	-	-	-	-	-	-	-	26	311
Accretion of premium on marketable securities
-	-	-	-	-	-2	-110	-697	-771	-511	-594
Revaluation of redeemable convertible preferred stock warrant liability
-	-	-	-	-	-	-	-	-	677	627
Loss on disposal of property and equipment
0	-8	-9	42	-32	-24	0	-1,551	-49	-148	50
Accretion of asset retirement obligation
-	-	-	-	-	-	-	30	39	146	43
Extinguishment of royalty payable
-	-	-	-	-	-	-	-	-	461	-
Stock-based compensation
6,943	7,889	7,091	5,673	5,126	4,620	4,389	5,076	9,431	8,737	4,822
Unrealized loss on investment in equity securities
-525	-83	0	0	-	-	-	-	-	-	-
Gain from extinguishment of asset retirement obligation
0	0	207	0	0	-	-	212	-124	0	-
Impairment of property and equipment
-	-	-	-	-	1,841	1,582	0	-	-	-
Gain on sale of Hungarian subsidiary
-	-	-	-	-	760	0	0	-	-	-
Loss on disposal and exchange of assets held for sale, net
-	-	-	-	-	-87	0	0	-	-	-
Change in fair value of assets held for sale
-	-	-	-	-	-698	2,179	0	0	-	-
Income tax benefit related to marketable securities
-	-	-	-	-314	0	68	-	-	-	-
Change in fair value of assets held for sale
-	-	-	-	-	-	0	0	-	-	-
Bad debt expense
-	-	-	-	-	-	-	-	-41	-	-
Changes in operating assets and liabilities:
Accounts receivable, net
-2,522	-960	5,298	-1,405	3,459	-1,587	-1,629	-11,372	3,583	8,087	1,054
Contract assets
992	35	0	0	-	-	-	-	-	-	-
Unbilled receivables
7,397	2,349	353	0	-	-	-	-	-	-	-
Inventories
-217	-447	210	-167	-403	-92	185	-3,186	1,671	-98	-58
Prepaid expenses and other current assets
1,412	37	-157	-7	-10	339	-850	3,051	682	-13	-11
Restricted cash
-	-	-	-	0	0	-	-	-	-	-
Other non-current assets
-88	-228	44	-52	16	78	-337	1,330	-513	-	-
Other non-current assets
-	-	-	-	-	-	1,857	0	0	-2,814	228
Accounts payable
-428	-524	-801	942	-1,274	713	308	-6,710	1,156	-2,105	1,068
Accrued compensation
-269	519	439	983	385	-530	130	-3,290	-1,322	1,589	2,434
Other accrued liabilities
2,474	-17	1,399	-593	-1,062	555	-2,724	197	4,351	-6,048	-3,792
Other long-term liabilities
-1,210	-904	0	0	-	-	-	-	-	-	-
Deferred revenue
-6,243	-10,631	11,017	-6,442	1,908	4,195	1,629	-1,789	-4,339	-15,131	530
Net cash used in operating activities
-12,560	-14,094	-8,755	-1,860	-433	321	-22,998	-11,892	-490	-16,383	-8,786
Investing activities:
Purchase of property and equipment
3,730	2,768	985	888	1,199	302	1,175	2,933	10,736	6,990	10,697
Other than temporary change in marketable securities
-	-	-	-	-	-	-	753	0	0	-
Proceeds from sale of Hungarian subsidiary, net of selling costs
-	-	-	-	-	-	-	68	0	0	-
Proceeds from disposal of property and equipment
3	2	2	42	18	167	238	0	0	15	-
Proceeds from sale of investment securities
62	0	0	-	-	-	-	-	-	-	-
Proceeds from sale of Hungarian subsidiary
-	-	-	-	-	1,500	0	0	-	-	-
Proceeds from sale of assets held for sale
-	-	-	-	-	282	0	0	-	-	-
Proceeds from sale of marketable securities
-	-	-	-	-	3,000	-	-	8,500	70,695	27,980
Purchase of marketable securities
-	-	-	-	-	-	-	20,638	52,564	49,051	37,118
Purchase of Maxygen patent portfolio
-	-	-	-	-	-	-	-	-	20,705	-
Proceeds from sale of marketable securities
-	-	-	-	-	-	0	10,397	6,037	1,605	-
Proceeds from maturities of marketable securities
-	-	-	-	-	-	13,409	29,885	-	-	-
Changes in restricted cash
-	-	-	-	76	0	-800	0	45	735	-193
Purchase of shares of CO2 Solution common shares
-	-	-	-	-	-	-	-	-	-	1,316
Net cash used in investing activities
-3,665	-2,766	-983	-846	-1,257	4,647	13,272	16,711	-48,808	-5,166	-20,958
Financing activities:
Proceeds from exercises of stock options
7,099	4,680	266	1,034	289	195	318	1,257	2,579	1,594	117
Proceeds from issuance of common stock in connection with public offering, net of underwriting discounts and commission
-	37,497	23,782	0	-	-	-	-	-	-	-
Principal payments on financing obligations
-	-	-	-	-	-	-	-	-	-8,026	-6,087
Costs incurred in connection with public offering
123	180	553	0	0	-	-	-	-	3,870	959
Proceeds from issuance of preferred stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	46,926
Proceeds from issuance of common stock in connection with private offering
50,000	-	-	-	0	9	0	0	-	72,541	-
Payments of lease obligations - Finance leases
242	238	175	0	0	-	-	-	-	-	-
Recovery of short swing profit
77	0	0	-	-	-	-	-	-	-	-
Taxes paid related to net share settlement of equity awards
2,850	3,190	1,670	1,524	1,813	815	465	0	0	-	-
Net cash used in financing activities
53,961	38,569	21,650	-490	-1,524	-611	-147	1,257	2,579	62,239	39,997
Net decrease in cash, cash equivalents and restricted cash
37,736	21,709	11,912	-3,196	-3,214	4,357	-9,873	6,241	-46,634	40,611	9,882
Effect of exchange rate changes on cash and cash equivalents
-	-	-	-	-	-	-	165	85	-79	-371
Supplemental disclosure of cash flow information
Interest paid
49	84	141	14	0	-	-	-	-	350	1,066
Income taxes paid
5	5	32	5	8	15	103	126	89	336	364
Supplemental non-cash investing and financing activities:
Equipment acquired under finance leases
0	0	862	0	0	-	-	-	-	-	-
Purchase of property and equipment recorded in accounts payable and accrued expenses
140	300	42	125	-	-	-	-	-	-	-
Equipment in property and equipment transferred from assets held for sale
-	-	-	-	-	-333	-	-	-	-	-
Reclassification of preferred stock warrant from liability to additional paid-in capital
-	-	-	-	-	-	-	-	-	2,686	-
Conversion of preferred stock to common stock and additional paid-in capital
-	-	-	-	-	-	-	-	-	179,672	-